The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

Author： Escalona Ruth M.   Chan Emily   Kannourakis George   Findlay Jock K.   Ahmed Nuzhat  

Publisher： MDPI

E-ISSN： 1422-0067|19|2|450-450

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.19, Iss.2, 2018-02, pp. : 450-450

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer

By Dobbin Zachary C.   Landen Charles N.  

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 8213-8227

MDPI

Access to resources Recommend Favorite

Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?

By Mittica Gloria   Genta Sofia   Aglietta Massimo   Valabrega Giorgio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1169-1169

MDPI

Access to resources Recommend Favorite

Endogenous Matrix-Derived Inhibitors of Angiogenesis

By Sund Malin   Nyberg Pia   Eikesdal Hans Petter  

Pharmaceuticals, Vol. 3, Iss. 10, 2010-09 ,pp. : 3021-3039

MDPI

Access to resources Recommend Favorite

HDAC6 and Ovarian Cancer

By Haakenson Joshua   Zhang Xiaohong  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9514-9535

MDPI

Access to resources Recommend Favorite

BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas

By Zhao Yang   Gou Wen-Feng   Chen Shuo   Takano Yasuo   Xiu Yin-Ling   Zheng Hua-Chuan  

International Journal of Molecular Sciences, Vol. 14, Iss. 10, 2013-09 ,pp. : 19670-19680

MDPI

Access to resources Recommend Favorite